Sunlife Sciences (P) Ltd. launches new division – Microlife

Sunlife Sciences (P) Ltd. has forayed into the critical care segment of the through its new division Microlife. The division will cater to demand in the Indian and international market for critical care drugs with a portfolio of 300+ medicines, with focus on cardiac and psychotropic range of medicines.

The division also has plans in 2020 to expand their reach and meet demand in the Indian generics market with a range of 200+ products.

Below is the range of products launched under the division in 2020.
Click here to Download